Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup...
A cash infusion from Nestle and an uptick in online consumer sales has buoyed ChromaDex as executives say the brand is on course to be in plus EBITDA territory by the end of fiscal 2022.
LA-based ChromaDex is partnering with MyPharma2Go Corporation to take Tru Niagen nicotinamide riboside into Brazil, focusing on reaching both consumers and Health Care Practitioners (HCPs).
The European Commission (EC) has agreed to amend the conditions of use for novel vitamin B3 ingredient nicotinamide riboside chloride (NR) in foods for special medical purposes and total diet replacement for weight control.
America’s nicotinamide riboside (NR) maker Chromadex is eyeing omnichannel retail in China and is confident of achieving the ‘blue-hat’ health foods registration status – required for normal trade of health foods in China – in the next 24 months or less....
Branded ingredient supplier ChromaDex announced an 18% sales gain in a recent earrings report. A continued push to increase the science behind its TruNiagen brand is part of the reason, the company’s co-founder said.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
Yasmeen Nkrumah-Elie, PhD, oversees external Research, managing a portfolio of over 200 studies, as well as supporting marketing, regulatory, and scientific affairs projects. The Global Director of External Research for ChromaDex has over 13 years of...
ChromaDex has announced its first major retailer deal for its NAD+ booster Tru Niagen, with the product set to be available in 3,000 Walmart stores across the U.S. beginning in June 2021.
Personalised nutrition and other specific therapeutic functions with a focus on changing the concept of ageing are the way forward for ChromaDex’s flagship nicotinamide riboside (NR) supplement, said the firm.
ChromaDex Corp., the California-based maker of nicotinamide riboside supplement Tru Niagen, expands its Canadian retail footprint to include all seven Whole Foods Markets in the province of Ontario.
New chief officers, presidents, directors, managers and more—here’s a cheat-sheet of who’s who and what’s new in the dietary supplements and natural products industry this summer.
A shift in market dynamics — not a legal dispute with a key customer — is what drove ChromaDex to try for a second time the finished products route for one of its branded ingredients.
ChromaDex is making progress on a transformation to a finished goods company based on its Niagen ingredient even as it struggles with continuing losses to shareholders.
Canadian supplement company NeutriSci has now dropped all sales of ChromaDex’s pTeroPure ingredient in favor of an energy product line based upon its PurEnergy ingredient, which is a pTeroPure/caffeine co crystal.
Branded dietary ingredient supplier ChromaDex reported record revenue in its second quarter 2015 earnings statement. It was the fifth consecutive quarter in which the company reached a new earnings plateau.
A single dose of nicotinamide riboside (NR) may significantly increases levels of NAD+, which is key to cellular energy metabolism and mitochondrial function, says a new study with healthy human volunteers using ChromaDex’s Niagen NR.
ChromaDex has bolstered the IP protection around pTeroPure, one of its branded ingredients, with the announcement of two patents relating to pterostilbene, which are the second and third patents granted to the company on the ingredient.
Chromadex has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, a move that will allow the Californian company to explore new topics and to accelerate its existing pipeline.
The first product containing Chromadex’s Niagen-branded nicotinamide riboside ingredient is being launched by High Performance Nutrition (HPN) to support neuroprotection in contact sports.
ChromaDex Corp. today announced the introduction of a new ingredient, called PURENERGY, which is a patented co-crystal ingredient comprised of caffeine and the company’s synthetic pterostilbene ingredient pTeroPure. The announcement comes on the heels...
PTeroPure maker ChromaDex has parted company with its president and director William Spengler, who has left to pursue other business interests after 14 months at the Californian firm.
Reference standards firm ChromaDex has added a new complete standard for testing stevia to its offerings, using the latest JECFA (Joint FAO/WHO Expert Committee on Food Additives) standard.
Alabama-based biotechnology firm DiscoveryBioMed (DBM) has partnered with Californian botanical specialist ChromaDex to tap into the group’s phytochemical expertise as it steps up work on the development of anti-inflammatory drugs.
ChromaDex is launching an ingredient with similar properties to resveratrol having obtained commercial rights to the biological compound from the University of Mississippi and the Agriculture Research Service (ARS).
